FDA Advisors to Weigh New Gene Therapy for Sickle Cell Anemia

MONDAY, Oct. 30, 2023 -- Patients with sickle cell disease may soon have two new treatments to try.On Tuesday, a U.S. Food and Drug Administration advisory committee will weigh the merits of a new gene therapy for the painful, inherited...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news